L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy.

Zeiter, Deborah; Vlajnic, Tatjana; Schötzau, Andreas; Heinzelmann-Schwarz, Viola; Montavon, Céline.

Afiliação

Zeiter D; Gynaecological Cancer Centre, Hospital for Women, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Vlajnic T; Institute of Pathology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Schötzau A; Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Heinzelmann-Schwarz V; Gynaecological Cancer Centre, Hospital for Women, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Montavon C; Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.

J Cancer ; 12(21): 6401-6410, 2021.

Article em En | MEDLINE | ID: mdl-34659530